|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Ideaya Biosciences, Inc. (IDYA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
72,130,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile IDEAYA Biosciences is a synthetic lethality-focused precision medicine oncology company engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Co.'s primary synthetic lethality product candidate is IDE397, a clinical-stage methionine adenosyltransferase 2a inhibitor for patients with solid tumors having methylthioadenosine phosphorylase deletions. Co. is enrolling patients into a Phase 1 clinical trial designated as IDE397-001 to evaluate IDE397. Co. is targeting poly (ADP-ribose) glycohydrolase for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
268,000 |
311,470 |
311,470 |
Total Sell Value |
$0 |
$10,832,803 |
$11,979,134 |
$11,979,134 |
Total People Sold |
0 |
3 |
4 |
4 |
Total Sell Transactions |
0 |
11 |
26 |
26 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Throne Jason |
Chief Legal Officer |
|
2023-09-01 |
4 |
AS |
$30.03 |
$63,063 |
D/D |
(2,100) |
0 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-09-01 |
4 |
OE |
$12.86 |
$27,006 |
D/D |
2,100 |
2,100 |
|
- |
|
Ruiz Briseno Andres |
See Remarks |
|
2023-09-01 |
4 |
AS |
$30.01 |
$60,016 |
D/D |
(2,000) |
32,531 |
|
- |
|
Stone Paul A. |
Chief Financial Officer |
|
2023-08-29 |
4 |
AS |
$28.87 |
$144,352 |
D/D |
(5,000) |
9,303 |
|
- |
|
Stone Paul A. |
Chief Financial Officer |
|
2023-08-21 |
4 |
AS |
$26.40 |
$25,819 |
D/D |
(978) |
14,303 |
|
- |
|
Stone Paul A. |
Chief Financial Officer |
|
2023-08-18 |
4 |
AS |
$26.38 |
$100,820 |
D/D |
(3,822) |
15,281 |
|
- |
|
Stone Paul A. |
Chief Financial Officer |
|
2023-08-16 |
4 |
AS |
$26.40 |
$5,285 |
D/D |
(200) |
19,103 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-08-09 |
4 |
AS |
$25.09 |
$125,430 |
D/D |
(5,000) |
0 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-08-09 |
4 |
OE |
$13.34 |
$66,700 |
D/D |
5,000 |
5,000 |
|
- |
|
Stone Paul A. |
Chief Financial Officer |
|
2023-08-09 |
4 |
AS |
$25.05 |
$62,613 |
D/D |
(2,500) |
19,303 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-07-10 |
4 |
AS |
$23.00 |
$218,178 |
D/D |
(9,485) |
0 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-07-10 |
4 |
OE |
$7.01 |
$95,740 |
D/D |
9,485 |
9,485 |
|
- |
|
Ruiz Briseno Andres |
See RemarksOfficer |
|
2023-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,531 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-06-01 |
4 |
AS |
$23.02 |
$81,792 |
D/D |
(3,553) |
0 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-06-01 |
4 |
OE |
$7.01 |
$24,907 |
D/D |
3,553 |
3,553 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-05-31 |
4 |
AS |
$23.00 |
$9,938 |
D/D |
(432) |
0 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-05-31 |
4 |
OE |
$7.01 |
$3,028 |
D/D |
432 |
432 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-05-22 |
4 |
AS |
$23.00 |
$11,500 |
D/D |
(500) |
0 |
|
- |
|
Throne Jason |
Chief Legal Officer |
|
2023-05-22 |
4 |
OE |
$7.01 |
$3,505 |
D/D |
500 |
500 |
|
- |
|
Stone Paul A. |
Chief Financial Officer |
|
2023-04-13 |
4 |
OE |
$4.62 |
$36,960 |
D/D |
8,000 |
21,803 |
|
- |
|
Hata Yujiro S |
President and CEO |
|
2023-04-12 |
4 |
OE |
$4.31 |
$50,000 |
D/D |
11,601 |
677,887 |
|
- |
|
Dillon Michael P. |
SVP, Chief Scientific Officer |
|
2021-10-04 |
4 |
AS |
$25.85 |
$39,545 |
D/D |
(1,500) |
78,789 |
|
- |
|
Dillon Michael P. |
SVP, Chief Scientific Officer |
|
2021-10-04 |
4 |
OE |
$11.08 |
$16,620 |
D/D |
1,500 |
80,289 |
|
- |
|
Dillon Michael P. |
SVP, Chief Scientific Officer |
|
2021-09-08 |
4 |
AS |
$27.41 |
$312,093 |
D/D |
(11,384) |
78,789 |
|
- |
|
Dillon Michael P. |
SVP, Chief Scientific Officer |
|
2021-09-08 |
4 |
OE |
$4.31 |
$78,264 |
D/D |
11,384 |
90,173 |
|
- |
|
129 Records found
|
|
Page 2 of 6 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|